1.94 0.00 (0.00%)
After hours: 4:12PM EDT
|Bid||1.92 x 1000|
|Ask||2.07 x 800|
|Day's Range||1.82 - 1.99|
|52 Week Range||1.62 - 10.25|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 5, 2018 - Nov 9, 2018|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||5.60|
Revenue increases 12% to $0.8 million, net loss narrows 21% to $3.3 million. Conference call begins at 4:30 p.m. Eastern time today. GAITHERSBURG, Md., Aug. 02, 2018-- OpGen, Inc. today reported financial ...
NEW YORK, NY / ACCESSWIRE / August 2, 2018 / OpGen, Inc. (NASDAQ: OPGN ) will be discussing their earnings results in their Q2 Earnings Call to be held on August 2, 2018 at 4:30 PM Eastern Time. To listen ...
Zacks.com featured highlights include: Hilton Grand, Fastenal, Catalyst Biosciences, OpGen and ConforMIS
Generally, investors love stocks with a low price-to-earnings (P/E) ratio. The idea is that the lower the P/E, the higher will be the value of the stock. The simple logic that a stock’s current market price does not validate (is not equivalent to) its higher earnings and therefore has room to run justifies investors’ inclination toward low P/E stocks.Source: ©iStock.com/CharlieAJA
GAITHERSBERG, Md., July 25, 2018-- OpGen, Inc. today announced that the Company will report financial results for the three and six months ended June 30, 2018 after close of the U.S. financial markets ...
On Thursday, July 19, 2018, the NASDAQ Composite, the Dow Jones Industrial Average, and the S&P 500 edged lower at the closing bell. Taking into consideration yesterday's market sentiment, WallStEquities.com assessed the following Healthcare equities this morning: OraSure Technologies Inc. (NASDAQ: OSUR), ResMed Inc. (NYSE: RMD), OpGen Inc. (NASDAQ: OPGN), and Organovo Holdings Inc. (NASDAQ: ONVO). On Thursday, shares in Bethlehem, Pennsylvania-based OraSure Technologies Inc. recorded a trading volume of 373,287 shares.
OpGen, Inc. (OPGN) today announced that it has negotiated modifications related to its $1,000,000 Second Amended and Restated Senior Secured Promissory Note (the “Note”), dated June 28, 2017, to extend the maturity of the note and to pay accrued interest through the issuance of shares of common stock. The Note is issued to Merck Global Health Innovation Fund, LLC (Merck GHI).
OpGen, Inc. (OPGN) today announced the presentation of data from the first phase of its Acuitas® urine clinical verification study demonstrating high accuracy in predicting antibiotic resistance in urine specimens. In the study, remnant urine specimens were provided by Intermountain Healthcare and Beth Israel Deaconess Medical Center and were tested with the Acuitas AMR Gene Panel u5.47 (Research Use Only ‘RUO’) to detect 5 pathogens and 47 resistance genes common to urinary tract infections. From the resulting genetic data, the Acuitas Lighthouse® Software (RUO) then predicted antibiotic resistance with greater than 90% accuracy.
GAITHERSBURG, Md., June 05, 2018-- OpGen, Inc. today announced that data on its Acuitas ® AMR Gene Panel u5.47 and Acuitas Lighthouse ® Knowledgebase will be presented at ASM Microbe 2018 being held June ...
LONDON, UK / ACCESSWIRE / May 31, 2018 / If you want a free Stock Review on ONVO sign up now at www.wallstequities.com/registration. Durham, North Carolina headquartered IQVIA Holdings Inc.'s stock finished Wednesday's session 1.31% higher at $100.48 with a total trading volume of 968,866 shares. Over the last month and the previous three months, the Company's shares have advanced 4.93% and 2.19%, respectively.
Newly public NeuroOne (NMTC) could be one of these movers in 2018 as they plan to file their first FDA medical device submission in the upcoming months. This technology addresses a large market opportunity and could support multiples of upside.
NEW YORK, NY / ACCESSWIRE / March 15, 2018 / OpGen, Inc. (NASDAQ: OPGN ) will be discussing their earnings results in their Q4 Earnings Call to be held on March 15, 2018, at 4:30 PM Eastern Time. To listen ...
Stock Monitor: VolitionRx Post Earnings Reporting LONDON, UK / ACCESSWIRE / March 15, 2018 / Active-Investors.com has just released a free research report on OpGen, Inc. (NASDAQ: OPGN ). If you want access ...
For investors with a long-term horizon, assessing earnings trend over time and against industry benchmarks is more valuable than looking at a single earnings announcement in one point in time.Read More...